AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21095149 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) therapy
Number of subjects: 119
Study 18978618 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 weeks of training on foot speed (FS) and choice reaction (REACT) drills
Number of subjects: 23
Study 18978618 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 23
Study 16973640 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital anesthesia (1% lidocaine)
Number of subjects: 55
Study 16973640 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia (1% lidocaine)
Number of subjects: 55
Study 14693302 — intervention group
Group type: EXPERIMENTAL
Intervention: SU + RSG
Number of subjects: 824
Study 14693302 — intervention group
Group type: COMPARATOR
Intervention: SU + placebo
Number of subjects: 824
Study 11027909 — intervention group
Group type: EXPERIMENTAL
Intervention: Active (deep) PC6 acupuncture
Number of subjects: 33
Study 11027909 — intervention group
Group type: COMPARATOR
Intervention: Placebo (superficial) acupuncture
Number of subjects: 33
Study 8932759 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 400 mu g inserted vaginally 12 hours before induced abortion (Group B)
Number of subjects: 129
Study 8932759 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 mu g inserted vaginally 12 hours before induced abortion (Group A)
Number of subjects: 129
Study 8932759 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 400 mu g orally 12 hours before induced abortion (Group C)
Number of subjects: 129
Study 1448663 — intervention group
Group type: EXPERIMENTAL
Intervention: CCNU 130 mg/m2, q.6 weeks
Number of subjects: 5
Study 1448663 — intervention group
Group type: EXPERIMENTAL
Intervention: VM‐26 100 mg/m2 on day 1, plus CCNU 130 mg/m2 on day 2, q.6 weeks
Number of subjects: 5
Study 1448663 — intervention group
Group type: EXPERIMENTAL
Intervention: HeCNU
Number of subjects: 5
Study 1448663 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizonidazole 12 mg/m2 total dose in 9 fractions
Number of subjects: 5
Study 1448663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 60 mg/m2 on days 1,8, 15 and 21 of radiation therapy
Number of subjects: 5
Study 1448663 — intervention group
Group type: EXPERIMENTAL
Intervention: Procarbazine, AZQ or DDMP used as single agents
Number of subjects: 5
Study 3881501 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (400 micrograms daily)
Number of subjects: 10
Study 3881501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30523750 — intervention group
Group type: COMPARATOR
Intervention: Letrozole (2.5 mg/d) for 14 weeks (Group A)
Number of subjects: 307
Study 30523750 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/d) plus letrozole for 14 weeks (Groups B, C, D)
Number of subjects: 307
Study 29768340 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular single-implant overdentures
Number of subjects: 22
Study 29768340 — intervention group
Group type: COMPARATOR
Intervention: Complete dentures
Number of subjects: 22
Study 27634790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (3 mg eszopiclone and 40% oxygen)
Number of subjects: 20
Study 24603733 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) applied by the therapist
Number of subjects: 14
Study 24603733 — intervention group
Group type: COMPARATOR
Intervention: Proprioceptive neuromuscular facilitation (PNF) self-administered using an elastic tube
Number of subjects: 14
Study 23217162 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Number of subjects: 70
Study 23217162 — intervention group
Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 70
Study 20214069 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming needle at spinal nerves in front of transverse posterior tubercle of cervical vertebra
Number of subjects: 180
Study 20214069 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at acupoints of cervical Jiaji (EX‐B 2)
Number of subjects: 180
Study 17411463 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with parental support
Number of subjects: 2991
Study 17411463 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group without parental support
Number of subjects: 2991
Study 17411463 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2991
Study 15772683 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimix (Tx) with varying doses of phentolamine (1 mg) and papaverine (5, 10, or 20 mg)
Number of subjects: 180
Study 15772683 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E1 (PgE1) at doses of 2.5, 5, or 10 microg
Number of subjects: 180
Study 12033713 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyrification patterns in individuals with WS
Number of subjects: 17
Study 12033713 — intervention group
Group type: COMPARATOR
Intervention: Typically developing control participants
Number of subjects: 17
Study 10741192 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms + Bupivacaine 2.5 mg
Number of subjects: 60
Study 10741192 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 10 micrograms + Bupivacaine 2.5 mg
Number of subjects: 60
Study 10741192 — intervention group
Group type: COMPARATOR
Intervention: Plain Bupivacaine 2.5 mg
Number of subjects: 60
Study 10741192 — intervention group
Group type: COMPARATOR
Intervention: Control (1 mL saline) + Bupivacaine 2.5 mg
Number of subjects: 60
Study 7746058 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin therapy
Number of subjects: 0
Study 7746058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2257859 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release theophylline 650 mg once daily in the evening
Number of subjects: 36
Study 2257859 — intervention group
Group type: COMPARATOR
Intervention: Controlled-release terbutaline 7.5 mg b.d.
Number of subjects: 36
Study 396305 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol and sucrose flavored gum
Number of subjects: 27
Study 396305 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol and sucrose flavored gum
Number of subjects: 27
Study 396305 — intervention group
Group type: COMPARATOR
Intervention: No oral hygiene control group
Number of subjects: 27
Study 29279188 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-day seizure frequency
Number of subjects: 120
Study 29279188 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month seizure frequency
Number of subjects: 120
Study 29279188 — intervention group
Group type: EXPERIMENTAL
Intervention: Total NHE count
Number of subjects: 120
Study 27604086 — intervention group
Group type: EXPERIMENTAL
Intervention: Calanus Oil (4g providing 260mg EPA and 156mg DHA)
Number of subjects: 18
Study 27604086 — intervention group
Group type: COMPARATOR
Intervention: Lovaza (1 capsule providing 465mg EPA and 375mg DHA)
Number of subjects: 18
Study 27604086 — intervention group
Group type: COMPARATOR
Intervention: Calanus Oil and Lovaza (comparison)
Number of subjects: 18
Study 25781221 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient-rich diet (green vegetables, beef, whole milk, full-fat butter) for three months
Number of subjects: 98
Study 25781221 — intervention group
Group type: EXPERIMENTAL
Intervention: Green vegetables according to diet guidelines
Number of subjects: 98
Study 25781221 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk consumed almost daily
Number of subjects: 98
Study 23791061 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold autologous blood cardioplegic solution
Number of subjects: 96
Study 23791061 — intervention group
Group type: COMPARATOR
Intervention: HTK solution
Number of subjects: 96
Study 23791061 — intervention group
Group type: COMPARATOR
Intervention: Cold non-autologous blood cardioplegic solution
Number of subjects: 96
Study 19879118 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure mastic gum 350mg tid for 14 days (Group A)
Number of subjects: 52
Study 19879118 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure mastic gum 1.05g tid for 14 days (Group B)
Number of subjects: 52
Study 19879118 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 20mg bd plus pure mastic gum 350mg tid for 14 days (Group C)
Number of subjects: 52
Study 19879118 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 20mg bd plus amoxicillin 1g bd plus clarithromycin 500mg bd for 10 days (Group D)
Number of subjects: 52
Study 17991875 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 2926
Study 17991875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2926
Study 16780616 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcysteine 1200 mg the day before and 600 mg at the operative day
Number of subjects: 31
Study 16780616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning
Number of subjects: 31
Study 16780616 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study 11153971 — intervention group
Group type: EXPERIMENTAL
Intervention: One-session exposure (E1)
Number of subjects: 46
Study 11153971 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-sessions exposure (E5)
Number of subjects: 46
Study 11153971 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-sessions cognitive therapy (C5)
Number of subjects: 46
Study 11153971 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 46
Study 9842028 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 25
Study 9842028 — intervention group
Group type: COMPARATOR
Intervention: Control group (no spinal cord stimulation)
Number of subjects: 25
Study 8186063 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg at 16.00 h)
Number of subjects: 0
Study 8186063 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI) (100 mg at 16.00 h)
Number of subjects: 0
Study 8186063 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 0
Study 8186063 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0
Study 2687687 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimantadine (200 mg per day for 10 days)
Number of subjects: 237
Study 2687687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study 8172091 — intervention group
Group type: EXPERIMENTAL
Intervention: 54 g psyllium-enriched cereal/d containing 7.3 g psyllium
Number of subjects: 18
Study 8172091 — intervention group
Group type: COMPARATOR
Intervention: 7.6 g of psyllium taken between meals
Number of subjects: 18
Study 215338 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol (30 g/day) and diet
Number of subjects: 25
Study 30910061 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketamine
Number of subjects: 53
Study 30910061 — intervention group
Group type: COMPARATOR
Intervention: Intravenous metoclopramide and diphenhydramine (control)
Number of subjects: 53
Study 28745354 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone therapy (80 mg day-1)
Number of subjects: 200
Study 26342471 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (Absorb BVS)
Number of subjects: 191
Study 26342471 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting metallic stent (EES)
Number of subjects: 191
Study 24345171 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Stroop color identification task (50% congruent/incongruent)
Number of subjects: 0
Study 24345171 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse Stroop word identification task (50%/50%)
Number of subjects: 0
Study 24345171 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse Stroop word identification task (80%/20%)
Number of subjects: 0
Study 24345171 — intervention group
Group type: EXPERIMENTAL
Intervention: NINC (frontocentral negative polarity incongruency wave)
Number of subjects: 0
Study 24345171 — intervention group
Group type: EXPERIMENTAL
Intervention: LPC (late positive component)
Number of subjects: 0
Study 22514508 — intervention group
Group type: EXPERIMENTAL
Intervention: PICO queries
Number of subjects: 22
Study 22514508 — intervention group
Group type: COMPARATOR
Intervention: Standard queries
Number of subjects: 22
Study 19295472 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 519
Study 18095506 — intervention group
Group type: EXPERIMENTAL
Intervention: On‐line guidance by multiplane TEE
Number of subjects: 55
Study 18095506 — intervention group
Group type: COMPARATOR
Intervention: On‐line guidance by intracardiac echocardiography
Number of subjects: 55
Study 15354150 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-rich diet supplying at least 1,500 mg of calcium per day
Number of subjects: 59
Study 15354150 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 59
Study 11965512 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacor (isolated soy protein with high levels of isoflavones and cotyledon soy fibres), given as two daily liquid supplements for 6 weeks
Number of subjects: 60
Study 11965512 — intervention group
Group type: COMPARATOR
Intervention: Placebo, given as two daily liquid supplements for 6 weeks
Number of subjects: 60
Study 10681768 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of 4000U SOD immediately after radiotherapy
Number of subjects: 159
Study 7716842 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg subcutaneously every 4 weeks and flutamide 250 mg orally three times daily 2 months before and during radiation therapy (Arm I)
Number of subjects: 456
Study 7716842 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy alone (Arm II)
Number of subjects: 456
Study 7716842 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin and flutamide (Arm I)
Number of subjects: 456
Study 2715477 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical evaluation (history, examination, imaging)
Number of subjects: 60
Study 2715477 — intervention group
Group type: COMPARATOR
Intervention: Arthrographic diagnosis
Number of subjects: 60
Study 4407 — intervention group
Group type: EXPERIMENTAL
Intervention: Clorimipramine
Number of subjects: 107
Study 4407 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepine
Number of subjects: 107
Study 4407 — intervention group
Group type: EXPERIMENTAL
Intervention: Dibenzepine
Number of subjects: 107
Study 31319828 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory Learning and Action (PLA) meetings with women's groups and home visits
Number of subjects: 4668
Study 31319828 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory Learning and Action (PLA) meetings, home visits, and crèches
Number of subjects: 4668
Study 31319828 — intervention group
Group type: COMPARATOR
Intervention: Control group (Area 1)
Number of subjects: 4668
Study 28011612 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 days of oral vancomycin followed by a single 500-mL fecal transplantation (FT) by enema
Number of subjects: 30
Study 28011612 — intervention group
Group type: COMPARATOR
Intervention: 6-week taper of oral vancomycin
Number of subjects: 30
Study 25893991 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoids mixture (diosmin, troxerutin, hesperidin)
Number of subjects: 134
Study 25893991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 23993864 — intervention group
Group type: EXPERIMENTAL
Intervention: REPYFLEC cognitive remediation (CR)
Number of subjects: 62
Study 23993864 — intervention group
Group type: COMPARATOR
Intervention: Leisure activities (control)
Number of subjects: 62
Study 21370406 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary nephrectomy
Number of subjects: 47
Study 21370406 — intervention group
Group type: COMPARATOR
Intervention: Alternative diagnoses consideration
Number of subjects: 47
Study 19686522 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence-contingent employment (n = 27)
Number of subjects: 128
Study 19686522 — intervention group
Group type: COMPARATOR
Intervention: Employment-only (control, n = 24)
Number of subjects: 128
Study 17386321 — intervention group
Group type: EXPERIMENTAL
Intervention: Helixone membrane
Number of subjects: 60
Study 17386321 — intervention group
Group type: COMPARATOR
Intervention: High-flux polysulfone membrane (HF80)
Number of subjects: 60
Study 15305403 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 9366
Study 15305403 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 9366
Study 15305403 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole plus Tamoxifen
Number of subjects: 9366
Study 11465583 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic group (no active warming)
Number of subjects: 20
Study 11465583 — intervention group
Group type: COMPARATOR
Intervention: Normothermic group (active forced-air warming)
Number of subjects: 20
Study 9928555 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete axillary dissection as part of radical mastectomy
Number of subjects: 0
Study 9928555 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified radical mastectomy or breast conservation approach with lumpectomy
Number of subjects: 0
Study 9928555 — intervention group
Group type: EXPERIMENTAL
Intervention: Level I-II dissection
Number of subjects: 0
Study 9928555 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymphadenectomy
Number of subjects: 0
Study 8306269 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioimmunodetection with anti-carcinoembryonic antigen MoAb FO23C5, radiolabelled with 131I
Number of subjects: 59
Study 8306269 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance imaging
Number of subjects: 59
Study 8306269 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography
Number of subjects: 59
Study 8306269 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonography
Number of subjects: 59
Study 3055930 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of beta-carotene daily
Number of subjects: 300
Study 3055930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 29776895 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate islet transplantation
Number of subjects: 50
Study 29776895 — intervention group
Group type: COMPARATOR
Intervention: Insulin therapy
Number of subjects: 50
Study 29776895 — intervention group
Group type: EXPERIMENTAL
Intervention: Islet transplantation
Number of subjects: 50
Study 29776895 — intervention group
Group type: EXPERIMENTAL
Intervention: Islet transplantation (no prior kidney graft)
Number of subjects: 50
Study 29776895 — intervention group
Group type: EXPERIMENTAL
Intervention: Islet transplantation (prior kidney graft)
Number of subjects: 50
Study 26990084 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 46
Study 25223504 — intervention group
Group type: EXPERIMENTAL
Intervention: St John's wort with metformin
Number of subjects: 20
Study 25223504 — intervention group
Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 20
Study 23953078 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer therapies and devices combined with comprehensive care plans involving adequate patient education
Number of subjects: 0
Study 21131672 — intervention group
Group type: EXPERIMENTAL
Intervention: Horticultural therapy-based programming (HT-based); implemented twice weekly for 6 weeks at 4 treatment sites.
Number of subjects: 0
Study 21131672 — intervention group
Group type: COMPARATOR
Intervention: Traditional activities (TA) programming; regular activities observed at comparison sites.
Number of subjects: 0
Study 18055486 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg loading dose (LD) and 10 mg maintenance dose (MD)
Number of subjects: 110
Study 18055486 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 600 mg loading dose (LD) and 75 mg maintenance dose (MD)
Number of subjects: 110
Study 16005674 — intervention group
Group type: COMPARATOR
Intervention: Climène (estradiol valerate 2 mg, from D1 to D21/cyproterone acetate 1 mg, from D12 to D21, followed by 7 days off)
Number of subjects: 143
Study 16005674 — intervention group
Group type: EXPERIMENTAL
Intervention: Climodiène (estradiol valerate 2 mg/dienogest 2 mg)
Number of subjects: 143
Study 12904855 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberoptic endoscopic evaluation of swallowing (FEES) performed within 48 h post‐extubation and on days 5, 9, and 14 for those with evidence of aspiration.
Number of subjects: 42
Study 12904855 — intervention group
Group type: COMPARATOR
Intervention: Control group (younger cohort <65 years)
Number of subjects: 42
Study 10596768 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc and copper salt supplementation
Number of subjects: 2
Study 10596768 — intervention group
Group type: COMPARATOR
Intervention: No zinc and copper salt supplementation (Control)
Number of subjects: 2
Study 8588386 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal nocturnal oxygen therapy
Number of subjects: 20
Study 8588386 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 20
Study 2006994 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine, 10 mg once daily (extended release)
Number of subjects: 12
Study 7006528 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and drainage (TV + D)
Number of subjects: 259
Study 7006528 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy and drainage (SV + D)
Number of subjects: 259
Study 7006528 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy without drainage (PCV)
Number of subjects: 259
Study 31493287 — intervention group
Group type: EXPERIMENTAL
Intervention: Betrixaban 80 mg qd for 35-42 days
Number of subjects: 959
Study 31493287 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 40 mg qd for 10 ± 4 days
Number of subjects: 959
Study 31476336 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin cancer screening (ever life-time skin examination)
Number of subjects: 60764
Study 31476336 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin cancer screening (skin examination in the current year)
Number of subjects: 60764
Study 31476336 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational differences in ever life-time skin examination
Number of subjects: 60764
Study 29665762 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg vitamin B6 (pyridoxine hydrochloride) before bed for five consecutive days
Number of subjects: 100